We are live on ! Find out more
GCP

GSA Capital Partners Portfolio holdings

AUM $1.59B
1-Year Est. Return 39.81%
This Fund
S&P 500
This Quarter Est. Return
+0.92%
1 Year Est. Return
+39.81%
3 Year Est. Return
+94.75%
5 Year Est. Return
+73.44%
10 Year Est. Return
+404.29%
AUM
$1.16B
AUM Growth
-$38.5M
Cap. Flow
-$16.1M
Cap. Flow %
-1.39%
Top 10 Hldgs %
4.12%
Holding
2,179
New
583
Increased
522
Reduced
502
Closed
562

Top Buys

Rank Stock Value
1
FLOT icon
iShares Floating Rate Bond ETF
FLOT
+$6.99M
2
RELY icon
Remitly
RELY
+$4.91M
3
VCSH icon
Vanguard Short-Term Corporate Bond ETF
VCSH
+$4.83M
4
LNG icon
Cheniere Energy
LNG
+$4.74M
5
MBLY icon
Mobileye
MBLY
+$4.61M

Top Sells

Rank Stock Value
1
NUVB icon
Nuvation Bio
NUVB
+$6.32M
2
ACN icon
Accenture
ACN
+$5.44M
3
JEF icon
Jefferies Financial Group
JEF
+$3.77M
4
QRVO icon
Qorvo
QRVO
+$3.63M
5
FYBR
Frontier Communications
FYBR
+$3.58M

Sector Composition

Rank Sector Weight
1 Healthcare 16.3%
2 Technology 15.76%
3 Financials 13.46%
4 Industrials 12.71%
5 Consumer Discretionary 10.82%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SANA icon
1501
Sana Biotechnology
SANA
$980M
$131K 0.01%
+32,222
New +$144K
EVTL icon
1502
Vertical Aerospace
EVTL
$173M
$130K 0.01%
+24,323
New +$123K
RCKT icon
1503
Rocket Pharmaceuticals
RCKT
$394M
$129K 0.01%
36,836
-187,440
-84% -$642K
COMP icon
1504
Compass
COMP
$9.66B
$128K 0.01%
+12,141
New +$111K
HYLN icon
1505
Hyliion Holdings
HYLN
$690M
$126K 0.01%
68,414
-2,789
-4% -$5.62K
NUVB icon
1506
Nuvation Bio
NUVB
$2.32B
$126K 0.01%
14,111
-1,021,081
-99% -$6.32M
OM icon
1507
Outset Medical
OM
$90.8M
$124K 0.01%
+33,372
New +$286K
OPRT icon
1508
Oportun Financial
OPRT
$372M
$122K 0.01%
23,075
-28,158
-55% -$149K
COYA icon
1509
Coya Therapeutics
COYA
$113M
$120K 0.01%
+20,701
New +$126K
SLND icon
1510
Southland Holdings
SLND
$31.4M
$120K 0.01%
+36,222
New +$143K
PERF icon
1511
Perfect Corp
PERF
$196M
$118K 0.01%
65,286
+2,971
+5% +$5.52K
SOPH icon
1512
SOPHiA GENETICS
SOPH
$647M
$117K 0.01%
24,967
+12,513
+100% +$56.7K
CMRC
1513
Commerce.com Inc Series 1
CMRC
$184M
$114K 0.01%
+27,790
New +$128K
BRLT icon
1514
Brilliant Earth
BRLT
$21.6M
$114K 0.01%
+65,326
New +$139K
LXEO icon
1515
Lexeo Therapeutics
LXEO
$378M
$114K 0.01%
+11,463
New +$105K
ESOA icon
1516
Energy Services of America
ESOA
$292M
$112K 0.01%
+13,654
New +$131K
DMAC icon
1517
DiaMedica Therapeutics
DMAC
$364M
$110K 0.01%
+13,864
New +$104K
INTZ
1518
Intrusion
INTZ
$17.3M
$110K 0.01%
95,514
+38,560
+68% +$60.8K
CRVS icon
1519
Corvus Pharmaceuticals
CRVS
$1.17B
$109K 0.01%
14,188
-387,219
-96% -$3.05M
EPM icon
1520
Evolution Petroleum
EPM
$131M
$108K 0.01%
+30,596
New +$129K
INTR icon
1521
Inter&Co
INTR
$2.33B
$108K 0.01%
12,703
-44,540
-78% -$394K
HNNA icon
1522
Hennessy Advisors
HNNA
$78.5M
$106K 0.01%
+11,077
New +$110K
TLRY icon
1523
Tilray
TLRY
$622M
$106K 0.01%
+11,784
New +$144K
ALXO icon
1524
ALX Oncology
ALXO
$290M
$105K 0.01%
92,654
+4,489
+5% +$6.8K
NVVE
1525
DELISTED
Nuvve Holding Corp
NVVE
$105K 0.01%
+2,289
New +$320K
59 60
61
62 63

Similar funds

NCL
Nishkama Capital LLC Dorado, Puerto Rico $1.58B AUM 123.32% 1-Year Est. Return
DG
DigitalBridge Group Boca Raton, Florida $1.58B AUM 62.54% 1-Year Est. Return
VNT
Vanguard National Trust Malvern, Pennsylvania $1.59B AUM
SS
Sunbelt Securities Houston, Texas $1.58B AUM 28.96% 1-Year Est. Return
GWANC
Guardian Wealth Advisors (North Carolina) Raleigh, North Carolina $1.59B AUM 15.17% 1-Year Est. Return
LCM
Lakewood Capital Management New York $1.58B AUM 0.92% 1-Year Est. Return
LCM
Landscape Capital Management Englewood, New Jersey $1.58B AUM 26.88% 1-Year Est. Return
FDCP
Foster Dykema Cabot & Partners Waltham, Massachusetts $1.57B AUM 20.41% 1-Year Est. Return

GSA Capital Partners's Q4 2025 Portfolio in Review

As of Q4 2025, GSA Capital Partners held 2,179 positions worth $1.16B, down 3.2% from $1.2B the previous quarter. Its ten largest holdings account for 4.1% of the portfolio.

GSA Capital Partners's Q4 2025 filing shows 583 new, 522 increased, 502 reduced and 562 closed positions. Its largest new stake was iShares Floating Rate Bond ETF: 137,329 shares worth $6.99M. The largest sale was Nuvation Bio, an estimated $6.32M.

By sector, the portfolio is most concentrated in Healthcare at 16% of assets, up from 16% a quarter earlier, followed by Technology and Financials.

  • GSA Capital Partners's largest Q4 2025 buy was iShares Floating Rate Bond ETF: 137,329 shares worth $6.99M.
  • GSA Capital Partners added most to Remitly in Q4 2025, an estimated $4.91M increase.
  • GSA Capital Partners's biggest Q4 2025 reduction was Nuvation Bio, cutting an estimated $6.32M.
  • GSA Capital Partners fully exited Jefferies Financial Group in Q4 2025, selling an estimated $3.77M.
  • GSA Capital Partners's ten largest holdings make up 4.1% of its $1.16B portfolio in Q4 2025.
  • GSA Capital Partners opened 583 new positions and closed 562 in Q4 2025.
  • GSA Capital Partners's portfolio value fell 3.2% quarter-over-quarter to $1.16B.

Based on GSA Capital Partners's 13F filing for Q4 2025, filed 6 Feb 2026.